Extracellular l-arginine Enhances Relaxations Induced by Opening of Calcium-Activated SKCa Channels in Porcine Retinal Arteriole

Int J Mol Sci. 2019 Apr 25;20(8):2032. doi: 10.3390/ijms20082032.

Abstract

We investigated whether the substrate for nitric oxide (NO) production, extracellular l-arginine, contributes to relaxations induced by activating small (SKCa) conductance Ca2+-activated potassium channels. In endothelial cells, acetylcholine increased 3H-l-arginine uptake, while blocking the SKCa and the intermediate (IKCa) conductance Ca2+-activated potassium channels reduced l-arginine uptake. A blocker of the y+ transporter system, l-lysine also blocked 3H-l-arginine uptake. Immunostaining showed co-localization of endothelial NO synthase (eNOS), SKCa3, and the cationic amino acid transporter (CAT-1) protein of the y+ transporter system in the endothelium. An opener of SKCa channels, cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA) induced large currents in endothelial cells, and concentration-dependently relaxed porcine retinal arterioles. In the presence of l-arginine, concentration-response curves for CyPPA were leftward shifted, an effect unaltered in the presence of low sodium, but blocked by l-lysine in the retinal arterioles. Our findings suggest that SKCa channel activity regulates l-arginine uptake through the y+ transporter system, and we propose that in vasculature affected by endothelial dysfunction, l-arginine administration requires the targeting of additional mechanisms such as SKCa channels to restore endothelium-dependent vasodilatation.

Keywords: NO synthase; calcium-activated potassium channel; cationic amino acid transporter; porcine; relaxation; retinal arterioles.

MeSH terms

  • Animals
  • Arginine / pharmacology*
  • Arterioles / drug effects
  • Arterioles / physiology*
  • Cationic Amino Acid Transporter 1 / metabolism
  • Extracellular Space / chemistry*
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Ion Channel Gating / drug effects*
  • Nitric Oxide Synthase Type III / metabolism
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Rats
  • Retinal Vessels / drug effects
  • Retinal Vessels / physiology*
  • Small-Conductance Calcium-Activated Potassium Channels
  • Swine
  • Vasodilation / drug effects*

Substances

  • Cationic Amino Acid Transporter 1
  • Pyrazoles
  • Pyrimidines
  • Small-Conductance Calcium-Activated Potassium Channels
  • cyclohexyl-(2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-yl)amine
  • Arginine
  • Nitric Oxide Synthase Type III